Furthermore, we observe that formononetin may attenuate the progression of I/R‐ and cisplatin‐triggered AKI by regulating the PRDM16/S100A6/PKC‐η/ROS/p38MAPK and JNK signaling pathways. The gene discussed is S100A6; the disease is acute kidney injury.